Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2003-6-6
pubmed:abstractText
Inflammation and hypercoagulability contribute to the development of acute cerebral ischemia. Both can be mediated by the CD40 system. This study investigated whether the CD40 system and related mediators are upregulated in patients with transient ischemic attack (TIA) or stroke.
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
1524-4628
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
34
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1412-8
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:12764232-Acute Disease, pubmed-meshheading:12764232-Antigens, CD40, pubmed-meshheading:12764232-Biological Markers, pubmed-meshheading:12764232-Blood Platelets, pubmed-meshheading:12764232-Brain Ischemia, pubmed-meshheading:12764232-C-Reactive Protein, pubmed-meshheading:12764232-CD4-Positive T-Lymphocytes, pubmed-meshheading:12764232-CD40 Ligand, pubmed-meshheading:12764232-Cell Count, pubmed-meshheading:12764232-Chemokine CCL2, pubmed-meshheading:12764232-Female, pubmed-meshheading:12764232-Flow Cytometry, pubmed-meshheading:12764232-Follow-Up Studies, pubmed-meshheading:12764232-Humans, pubmed-meshheading:12764232-Ischemic Attack, Transient, pubmed-meshheading:12764232-Male, pubmed-meshheading:12764232-Middle Aged, pubmed-meshheading:12764232-Monocytes, pubmed-meshheading:12764232-P-Selectin, pubmed-meshheading:12764232-Platelet Adhesiveness, pubmed-meshheading:12764232-Receptors, Interleukin-2, pubmed-meshheading:12764232-Reference Values, pubmed-meshheading:12764232-Up-Regulation
pubmed:year
2003
pubmed:articleTitle
Upregulation of CD40-CD40 ligand (CD154) in patients with acute cerebral ischemia.
pubmed:affiliation
Medical Clinic II, Friedrich-Alexander-University Erlangen-Nuremberg, David-Morgenstern-Weg 14, 91056 Erlangen, Germany. Christoph.Garlichs@rzmail.uni-erlangen.de
pubmed:publicationType
Journal Article, Clinical Trial, Controlled Clinical Trial, Research Support, Non-U.S. Gov't